Corcept Therapeutics stock price rises after director increases holdings

LootboxPhobia · 2026-03-20T21:48:42+00:00

Corcept Therapeutics stock price rose 4.2% after director G. Leonard Baker Jr. purchased 100,000 shares. According to SEC filings, he acquired 75,782 shares and 24,218 shares at weighted average prices, bringing his holdings to 1,146,631 shares. The share purchase may reflect confidence in the company's prospects.

LootboxPhobia

2026-03-20 21:48:42

Abstract generation in progress

Investing.com – Corcept Therapeutics Incorporated (NASDAQ: CORT) stock price rose 4.2% on Friday, after director G. Leonard Baker Jr. purchased 100,000 shares of common stock.

According to Form 4 filed with the U.S. Securities and Exchange Commission, Baker bought 75,782 shares at an average price of $33.0022 on March 17, and 24,218 shares at an average price of $33.5633. These transactions increased Baker’s direct holdings to 1,146,631 shares.

After the purchases, Baker indirectly owns 3,308,303 shares through a limited partnership and 1,095,262 shares through a trust. Baker serves as a trustee for a trust that is the general partner of the limited partnership, and he is also the trustee of the trust holding the indirect shares.

These stocks were purchased through multiple transactions at prices ranging from $32.43 to $33.68 per share. Insider buying may indicate confidence in the company’s prospects, but it does not guarantee future performance.

This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.